Search results for "Vaseline"
showing 3 items of 3 documents
Anesthetic efficacy of Oraqix versus Hurricaine and placebo for pain control during non-surgical periodontal treatment
2014
Objectives: To evaluate the efficacy of Oraqix® during scaling and root planing (SRP) in comparison with 20% benzocaine and placebo. Study Design: 15 patients requiring 4 sessions of SRP were enrolled. For each patient, Oraqix®, Hurricaine®, vaseline or no anesthetic product were randomly assigned each to a quadrant. Treatment pain was evaluated on a 100 mm Visual Analog Scale (VAS) and on a Verbal Rating Scale (VRS). The amount of product administered, the need to re-anesthetise, patient and operator satisfaction and the onset of side-effects were also recorded. Results: Oraqix® was significantly better than nothing, with a reduction of VAS score to 13.3 units, but without significant diff…
Adhesives and mounting media in aerobiological sampling
1989
Abstract Because microscopical identification and counting is vital in most aerobiological studies, pollen and spores are usually collected on some adhesive. The adhesives should not be water-soluble. For optically best results water-soluble mounting media with refractive indices about 1.40–1.45 are used. There are compatibility problems between water insoluble adhesives and watery mounting media. The former tend to move to stripes or droplets, distorting the image and moving the spores from their original positions. To solve this problem several adhesives based on silicone oils, silicone greases and vaseline or their mixtures were tested. The usual watery mounting media, glycerine gelatine…
3PC-030 Physical, chemical and microbiological stability of sirolimus 0.4% in topical formulations
2019
Background Facial angiofibromas in tuberous sclerosis are an aesthetic problem within the clinical context of the disease. There are currently few stability studies that allow selecting the best topical sirolimus therapy. Purpose To improve the formulation of sirolimus 0.4% for the treatment of facial angiofibromas in tuberous sclerosis and to determine the period of validity (physical, chemical and microbiological stability) of the proposed formulations. Material and methods Three formulations of sirolimus 0.4% were prepared (each in duplicate, A and B). Facilities and equipment: biological safety cabinet with individual protection equipment for the manipulator. Conditions: aluminum tubes,…